Web Results

Plerixafor

en.wikipedia.org/wiki/Plerixafor

Plerixafor is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients ... Trade names, Mozobil. AHFS/Drugs.com · Consumer Drug ...

Mozobil

www.mozobil.com/

Official site from Genzyme Corporation. Contains consumer and prescribing information.

About Mozobil | Mozobil (plerixafor injection)

www.mozobil.com/healthcare/about

Learn more about Mozobil (plerixafor injection). The Mozobil Professional website is designed to help healthcare professionals care for their patients with ...

Mozobil (plerixafor) Uses, Dosage, Side Effects - Drugs.com

www.drugs.com/mozobil.html

Mozobil helps patients with non-Hodgkin's lymphoma by releasing stem cells that can be collected and transplanted back. Learn about side effects, interactions ...

Mozobil (plerixafor) injection label - FDA

www.accessdata.fda.gov/drugsatfda_docs/label/2010/022311s001lbl.pdf

MOZOBIL. MOZOBIL (plerixafor injection), Solution for Subcutaneous use ... Initiate Mozobil treatment after the patient has received G-CSF once daily for 4 days.

European Medicines Agency - Find medicine - Mozobil

www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001030/human_med_000910.jsp&mid=WC0b01ac058001d124

Next tab ». This is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP) ...

Mozobil New FDA Drug Approval | CenterWatch

www.centerwatch.com/drug-information/fda-approved-drugs/drug/1009/mozobil-plerixafor-injection

Mozobil (plerixafor injection): For the treatment of non-Hodgkin's lymphoma and multiple myeloma. New approved drug details including side effects, uses and ...

MOZOBIL® (plerixafor) Injection, for subcutaneous use Prescribing ...

products.sanofi.us/Mozobil/mozobil.html

Mozobil, a hematopoietic stem cell mobilizer, is indicated in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells ...

FDA Approves Genzyme's Mozobil | Sanofi Genzyme News

news.genzyme.com/press-release/fda-approves-genzymes-mozobil

Dec 15, 2008 ...Mozobil is an important advancement in the treatment of patients with certain types of cancer who require a stem cell transplant,” said John F.

Mozobil 20 mg/ml solution for injection - Summary of Product ...

www.medicines.org.uk/emc/medicine/22187/SPC/Mozobil 20 mg ml solution for injection

Apr 1, 2015 ... Mozobil is indicated in combination with granulocyte-colony stimulating factor (G- CSF) to enhance mobilisation of haematopoietic stem cells to ...

More Info

Why Mozobil? | Mozobil (plerixafor injection)

www.mozobil.com

Mozobil (plerixafor injection) is approved by the United States Food and Drug Administration (FDA) to be used with another agent, granulocyte-colony ...

Mozobil (Plerixafor Injection): Side Effects, Interactions, Warning ...

www.rxlist.com

Mozobil (plerixafor injection) is a sterile, preservative-free, clear, colorless to pale yellow, isotonic solution for subcutaneous injection. Each mL of the sterile ...

Common Side Effects of Mozobil (Plerixafor Injection) Drug Center ...

www.rxlist.com

Aug 27, 2015 ... Find a comprehensive guide to possible side effects including common and rare side effects when taking Mozobil (Plerixafor Injection) for ...